1. Home
  2. HP vs LQDA Comparison

HP vs LQDA Comparison

Compare HP & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Helmerich & Payne Inc.

HP

Helmerich & Payne Inc.

HOLD

Current Price

$39.31

Market Cap

3.7B

Sector

Energy

ML Signal

HOLD

LQDA

Liquidia Corporation

HOLD

Current Price

$37.67

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HP
LQDA
Founded
1920
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.1B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
HP
LQDA
Price
$39.31
$37.67
Analyst Decision
Hold
Strong Buy
Analyst Count
12
11
Target Price
$34.17
$41.00
AVG Volume (30 Days)
997.5K
1.0M
Earning Date
05-06-2026
05-08-2026
Dividend Yield
2.59%
N/A
EPS Growth
N/A
51.81
EPS
N/A
N/A
Revenue
$3,746,013,000.00
$158,320,000.00
Revenue This Year
$9.50
$278.87
Revenue Next Year
$3.34
$57.13
P/E Ratio
N/A
N/A
Revenue Growth
35.89
1031.18
52 Week Low
$14.65
$11.85
52 Week High
$39.05
$46.67

Technical Indicators

Market Signals
Indicator
HP
LQDA
Relative Strength Index (RSI) 67.12 49.81
Support Level $32.88 $31.75
Resistance Level N/A $39.19
Average True Range (ATR) 1.16 2.03
MACD 0.48 -0.24
Stochastic Oscillator 94.53 28.39

Price Performance

Historical Comparison
HP
LQDA

About HP Helmerich & Payne Inc.

Helmerich & Payne Inc provides performance-driven drilling solutions and technologies to make hydrocarbon recovery safer and more economical for oil and gas exploration and production companies. Focusing on the drilling segment, its technology services develop and commercialize solutions that improve drilling efficiency, accuracy, and wellbore quality and placement. The company operates through North America Solutions, International Solutions, and Offshore Solutions segments. The North America segment runs a technologically advanced AC drive drilling rig fleet in the U.S., with a presence in shale and unconventional basins, while the Offshore Solutions segment, operating rigs on fixed-leg and floating platforms, generates the majority of revenue.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

Share on Social Networks: